31例高龄脑出血临床特点分析

Clinical Trail Experience of Using Recombinant Human Granulocyte Colony StimulatingFactor

对３１例高龄脑出血病人的发病季节、病因、起病状态、发病早期血压变化、ＣＴ或ＭＲＩ扫描结果以及临床特点进行分析，结果说明４月份至８月份发病及活动中发病较高。男性发病高于女性，左右半球出血的发生率差异不大。出血部位，出血量的大小以及并发症与疾病的转归有着密切的关系。

From January 1994 to January 1995 ,22 cancer patients with leukopenia and neutropenia Caused by chemotherapy and radiotherapy were treated with recombinant human granulocyte colony stimulating factor (rhG-CSF, Filgrastim by kirin co. Japan).The results showed that rhG-CSF co. Japan). The results showed that rhG-CSF significantly increased the total white cell count and absolute neutrophil count. But rhG-CSF display little effect onplatelet and hemoglobin. Special side-effect of rhG-CSF had not been found during this time.